Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Temozolomide as a Single Agent Maintenance Therapy in Elderly Patients With Primary CNS Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 18, 2019
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.
Journal: Neuro-oncology
Published: May 05, 2017
The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 27, 2016
High-dose methotrexate-based chemotherapy as treatment for histiocytic sarcoma of the central nervous system.
Journal: Leukemia & lymphoma
Published: January 05, 2016
Clinical Reasoning: Worsening neurologic symptoms in a brain tumor patient.
Journal: Neurology
Published: August 19, 2015
Prevalence of hepatitis B virus in primary central nervous system lymphoma.
Journal: Journal of neuro-oncology
Published: December 11, 2014
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 10, 2014
Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide.
Journal: Leukemia & lymphoma
Published: April 22, 2014
CNS involvement at diagnosis in mantle cell lymphoma with atypical MRI features.
Journal: Journal of neurology
Published: January 14, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026